Host: Manchester Pharmacy School
About the event:
Title: 'Clinical Mass Spectrometry - The use of mass spectrometry in a routine clinical environment for the quantification of drugs and metabolites, and the investigation of protein variants'.
This lecture will look at the use of mass spectrometry in a routine clinical environment for the quantification of drugs and metabolites, and the investigation of protein variants. Delivered by Professor Mike Morris – the British Mass Spectrometry Society Lecturer for 2014 as part of his National lecture tour.
The seminar series held in MPS is primarily designed to be of interest to staff and students in Pharmacy and Pharmaceutical Science. However, often speakers are drawn from other disciplines (Social Sciences, Economics, Epidemiology, Chemistry, Materials Science, Pharmacology etc); in addition, there may well be a disease focus which would fit with the broad interests of FMHS. Thus the MPS Seminar Series is likely to of interest to staff and students more broadly in the University.
Professor Mike Morris
Professor Michael Morris is the Senior Director of Mass Spectrometry Research at Waters Corporation, based in Manchester, England.
Professor Morris received his B.Sc. (Hons) in Analytical Chemistry from UMIST, Manchester in 1985, and a Ph.D. in mass spectrometry from the same institution in 1988 under the supervision of the late Professor Michael Barber FRS. He has been involved in a number of research projects, including the ion optic design of sector instruments, development of surface-induced dissociation and the application of tandem mass spectrometry. He spent time working in Japan (Osaka University), USA (Purdue University) and Canada (National Research Council) before joining Micromass/Waters in 1994.
Professor Morris founded the Clinical Operations Group in Waters in 1999, and was responsible for the development of applications of mass spectrometry in neonatal screening, therapeutic drug monitoring and clinical toxicology. This technology is now in wide use around the world for routine clinical chemistry analysis. He rejoined the mass spectrometry research team in 2010.
Professor Morris has been the co-organiser of a number of national and international meetings and authored more than 50 publications. He is also a Chartered Chemist and Fellow of the Royal Society of Chemistry (C.Chem., F.R.S.C.). In 2012 he was appointed as a visiting Professor in the Department of Surgery and Cancer at Imperial College, London.